Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Director
Dr Marielle Scherrer-Crosbie is the Director of the Echocardiography Laboratory at the Hospital of the University of Pennsylvania, Philadelphia, Philadelphia, US. Her main research interests are in the use of imaging and biomarkers in cardio-oncology both in human populations and in small animal models. She also uses small animal models in studying subclinical cardiac dysfunction in metabolic… View more
Evandro de Azambuja
Research Area(s) / Expertise:

Cardio-oncology

 Job title: Head of the Medical Support Team, Jules Bordet Insitute, Brussels, Belgium
Evandro de Azambuja, MD, PhD, leads the Medical Support Team (Academic Promoting Team) at the Jules Bordet Institute in Brussels, Belgium. In this role, he oversees 4-5 research fellows and provides medical supervision for large phase III clinical trials, particularly in breast cancer.Dr. de Azambuja holds two PhDs, one from the Federal University of Rio Grande do Sul, Porto Alegre, Brazil, in… View more
Lawrence N. Shulman
Job title: Deputy Director
Dr Lawrence N Shulman is Deputy Director for Clinical Services at the Abramson Cancer Center at the University of Pennsylvania. He is also Director of the Center for Global Cancer Medicine. Currently Dr Shulman is Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. Formerly, he was Chair of the American Society of Clinical Oncology Quality… View more
AHA 2020: RHAPSODY Phase 3 Trial — Dr Allan Klein
Author(s): Allan L Klein Added: 3 years ago
Dr Allan Klein (Cleveland Clinic, Cleveland, Ohio, US) discusses the positive results of the Phase 3 RHAPSODY trial. The trial is investigating the use of rilonacept, an IL-1α And IL-1β trap, in resolving and reducing the risk of recurrence in patients with recurrent pericarditis. Questions: 1. What is the background of this study? 2. What is the study design? 3. What were the results? 4… View more

Pericardium Disorders
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 43,200 people in 80 countries, and markets its… View more
Joerg Herrmann
Research Area(s) / Expertise:

Cardio-oncology

Atherosclerosis and Hyperlipidemia

 Job title: Director, Cardio-Oncology Clinic, Mayo Clinic, Rochester, US
Joerg Herrmann, M.D., is a cardiologist researching how cancer and heart disease interact. Dr. Herrmann's research focuses on cardio-oncology, which studies the potential negative effects of cancer treatments on the circulatory system. Additionally, Dr. Herrmann is very interested in vascular illnesses, particularly the formation of atherosclerotic plaques and their effects. His work also… View more
Duk-Woo Park
Job title: Professor of Medicine
Prof Duk-Woo Park is Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine.Prof Park has a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major… View more